You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

CLINICAL TRIALS PROFILE FOR ALMOTRIPTAN MALATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for almotriptan malate

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00210483 ↗	A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents	Completed	Ortho-McNeil Neurologics, Inc.	Phase 3	2003-07-01	The purpose of this study is to evaluate the effectiveness and safety of almotriptan malate (AXERT®) in treating acute migraine headaches in adolescents. Amotriptan malate (AXERT®) is approved for use in the treatment of acute migraine headache with or without aura in adults. In this study, adolescents will be given a single dose of study medication to treat one migraine headache.
NCT00210483 ↗	A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents	Completed	Janssen-Ortho LLC	Phase 3	2003-07-01	The purpose of this study is to evaluate the effectiveness and safety of almotriptan malate (AXERT®) in treating acute migraine headaches in adolescents. Amotriptan malate (AXERT®) is approved for use in the treatment of acute migraine headache with or without aura in adults. In this study, adolescents will be given a single dose of study medication to treat one migraine headache.
NCT00210496 ↗	Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 4	2005-06-01	The purpose of this study is to evaluate the impact of topiramate (migraine prevention medicine) on the effectiveness of almotriptan malate (acute migraine medicine) when treating acute migraine headaches.
NCT00210496 ↗	Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine	Completed	Janssen-Ortho LLC	Phase 4	2005-06-01	The purpose of this study is to evaluate the impact of topiramate (migraine prevention medicine) on the effectiveness of almotriptan malate (acute migraine medicine) when treating acute migraine headaches.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for almotriptan malate

Condition Name

Chart
Table

Condition Name for almotriptan malate
Intervention	Trials
Migraine	5
Classic Migraine	1
Common Migraine	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for almotriptan malate
Intervention	Trials
Migraine Disorders	5
Headache	1
Migraine without Aura	1
Migraine with Aura	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for almotriptan malate

Trials by Country

Map
Table

Trials by Country for almotriptan malate
Location	Trials
United States	23
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for almotriptan malate
Location	Trials
Utah	1
Texas	1
Tennessee	1
Pennsylvania	1
Oklahoma	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for almotriptan malate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for almotriptan malate
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for almotriptan malate
Clinical Trial Phase	Trials
Completed	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for almotriptan malate

Sponsor Name

Chart
Table

Sponsor Name for almotriptan malate
Sponsor	Trials
Ortho-McNeil Neurologics, Inc.	4
Janssen-Ortho LLC	4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for almotriptan malate
Sponsor	Trials
Industry	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.